Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norfloxacin vs Nitazoxanide vs Colistin for SBP Prophylaxis
NCT06827756Phase 4Completed
- Sponsor
- Tanta University
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nitazoxanide and colistin in spontaneous bacterial peritonitis (SBP) (3 arms), sponsored by Tanta University. Primary endpoint: Recurrence of Spontaneous Bacterial Peritonitis at 6 months. Started Mar 2021; status: completed.
02
Drugs
nitazoxanidecolistin
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT06827756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06827756.